ENVB Enveric Biosciences Inc

USD 1.00 -0.02 -1.960784
Icon

Enveric Biosciences Inc (ENVB) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1

-0.02 (-1.96)%

USD 3.86M

0.27M

N/A

USD 9.50 (+850.00%)

Icon

ENVB

Enveric Biosciences Inc (USD)
COMMON STOCK | NSD
USD 1.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.86M

USD 9.50 (+850.00%)

USD 1.00

Enveric Biosciences Inc (ENVB) Stock Forecast

N/A

Based on the Enveric Biosciences Inc stock forecast from 0 analysts, the average analyst target price for Enveric Biosciences Inc is not available over the next 12 months. Enveric Biosciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Enveric Biosciences Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Enveric Biosciences Inc’s stock price was USD 1. Enveric Biosciences Inc’s stock price has changed by -14.53% over the past week, +20.34% over the past month and -37.50% over the last year.

No recent analyst target price found for Enveric Biosciences Inc
No recent average analyst rating found for Enveric Biosciences Inc

Company Overview Enveric Biosciences Inc

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is EB-373, an active metabolite of psilocybin, which is in Phase 1 clinical trials for...Read More

https://www.enveric.com

4851 Tamiami Trail N, Naples, FL, United States, 34103

25

December

USD

USA

Adjusted Closing Price for Enveric Biosciences Inc (ENVB)

Loading...

Unadjusted Closing Price for Enveric Biosciences Inc (ENVB)

Loading...

Share Trading Volume for Enveric Biosciences Inc Shares

Loading...

Compare Performance of Enveric Biosciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ENVB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Enveric Biosciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing ENVB

Symbol Name ENVB's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Enveric Biosciences Inc (ENVB) Stock

Stock Target Advisor's fundamental analysis for Enveric Biosciences Inc's stock is Bearish.

Unfortunately we do not have enough data on ENVB's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ENVB's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ENVB's stock to indicate if its overvalued.

The last closing price of ENVB's stock was USD 1.00.

The most recent market capitalization for ENVB is USD 3.86M.

Unfortunately we do not have enough analyst data on ENVB's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Enveric Biosciences Inc's stock.

As per our most recent records Enveric Biosciences Inc has 25 Employees.

Enveric Biosciences Inc's registered address is 4851 Tamiami Trail N, Naples, FL, United States, 34103. You can get more information about it from Enveric Biosciences Inc's website at https://www.enveric.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...